---
Investor Relations

Price: ... AWKN (NEO)

About Awakn

Awakn Life Sciences is a biotechnology company with clinical operations, developing and delivering psychedelic therapeutics (medicines and therapies) to better treat addiction. Awakn’s team consists of world leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction. Awakn will deliver these evidence backed psychedelic therapies in clinics in the UK and Europe and through licensing partnerships globally.

Awakn corporate information

Download latest Awakn Corporate Presentation and visit Awakn Financials Info on Sedar page.

Presentations

Press releases

Enquiries

Investor relations:

KCSA Strategic Communications
Valter Pinto / Tim Regan
Phone: +1 (212) 896-1254
awakn@KCSA.com

Media enquiries:

AMERICA AND CANADA:
KCSA Strategic Communications 
Anne Donohoe
adonohoe@KCSA.com

REST OF WORLD:
ROAD Communications
Paul Jarman / Anna Ramsey
awakn@roadcommunications.co.uk

Sign Up for Newsletter

Awakn_logo_corp

MAIN OFFICE
301-217 Queen St. W, Toronto, ON, M5V 0R2, Canada

UK OFFICE
1 Regent Street, Bristol, BS8 4HW, United Kingdom

© 2021 Awakn Life Sciences Corp      |      Privacy Policy      |      Appropriate Use Policy

<>
Back to top Arrow